表紙
市場調查報告書
商品編碼
1067500

食慾抑制劑的全球市場(2022年∼2026年)

Global Anorexiants Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球食慾抑制劑的市場規模在2022年∼2026年的預測期間內預計將以4.62%的年複合成長率推移,並成長到10億5,000萬美元。

市場成長的主要因素有肥胖人口的增加,政府對醫療基礎設施的配合措施增加,合併·收購(M&A)活動等的供應商策略等。

本報告提供全球食慾抑制劑市場調查,提供市場概要,市場規模和預測,趨勢,成長要素及課題,客戶形勢,流通管道·各地區的分析,再加上業者情勢及供應商分析等資訊。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:從2021年∼2026年的預測

第4章 波特的五力分析

  • 五力摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

第5章 各流通管道的市場區隔

  • 市場區隔
  • 各流通管道比較
  • 醫院藥局:市場規模與預測(2021年∼2026年)
  • 零售藥局:市場規模與預測(2021年∼2026年)
  • 線上藥局:市場規模與預測(2021年∼2026年)
  • 各流通管道的市場機會

第6章 客戶形勢

  • 客戶形勢概要

第7章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2021年∼2026年)
  • 歐洲:市場規模與預測(2021年∼2026年)
  • 亞洲:市場規模與預測(2021年∼2026年)
  • 其他地區:市場規模與預測(2021年∼2026年)
  • 美國:市場規模與預測(2021年∼2026年)
  • 加拿大:市場規模與預測(2021年∼2026年)
  • 英國:市場規模與預測(2021年∼2026年)
  • 德國:市場規模與預測(2021年∼2026年)
  • 日本:市場規模與預測(2021年∼2026年)
  • 中國:市場規模與預測(2021年∼2026年)
  • 各地區形勢的市場機會

第8章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 成長要素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂形勢
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Arena Pharmaceuticals Inc.
  • Epic Pharma LLC
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson
  • Lannett Co. Inc.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Recordati SpA
  • Teva Pharmaceutical Industries Ltd.
  • VIVUS LLC

第11章 附錄

  • 調查範圍
  • 包含和排除清單
  • 美金的匯率
  • 調查手法
  • 簡稱的清單
目錄
Product Code: IRTNTR72903

Technavio has been monitoring the anorexiants market and it is poised to grow by $ 1.05 bn during 2022-2026 progressing at a CAGR of 4.62% during the forecast period. Our report on the anorexiants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing obese population, increasing government initiatives for healthcare infrastructure, and vendors strategies such as mergers and acquisition (M and A) activities.

The anorexiants market analysis includes the distribution channel segment and geographic landscape.

Technavio's anorexiants market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the research and approval of new drugs as one of the prime reasons driving the anorexiants market growth during the next few years. Also, awareness about weight management and increase in childhood obesity and morbid obesity incidence will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anorexiants market covers the following areas:

  • Anorexiants market sizing
  • Anorexiants market forecast
  • Anorexiants market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anorexiants market vendors that include Arena Pharmaceuticals Inc., Bausch Health Companies Inc., Currax Pharmaceuticals LLC, Elite Pharmaceuticals Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Hi Tech Pharmaceuticals, Johnson and Johnson, KVK Tech Inc., Lannett Co. Inc., Novartis AG, Novo Nordisk AS, Nuvo Pharmaceuticals Inc., Pfizer Inc., Recordati SpA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Virtus Nutrition LLC., VIVUS LLC, and Zydus Lifesciences Ltd. Also, the anorexiants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Distribution Channel

  • 5.1 Market segments
  • Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
  • 5.2 Comparison by Distribution Channel
  • Exhibit 26: Chart on Comparison by Distribution Channel
  • Exhibit 27: Data Table on Comparison by Distribution Channel
  • 5.3 Hospital pharmacy - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
  • 5.4 Retail pharmacy - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Retail pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Retail pharmacy - Year-over-year growth 2021-2026 (%)
  • 5.5 Online pharmacy - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Online pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Online pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Online pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Online pharmacy - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Distribution Channel
  • Exhibit 40: Market opportunity by Distribution Channel ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 Japan - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.12 China - Market size and forecast 2021-2026
  • Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity By Geographical Landscape
  • Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 92: Matrix on vendor position and classification
  • 10.3 Arena Pharmaceuticals Inc.
  • Exhibit 93: Arena Pharmaceuticals Inc. - Overview
  • Exhibit 94: Arena Pharmaceuticals Inc. - Product / Service
  • Exhibit 95: Arena Pharmaceuticals Inc. - Key offerings
  • 10.4 Epic Pharma LLC
  • Exhibit 96: Epic Pharma LLC - Overview
  • Exhibit 97: Epic Pharma LLC - Product / Service
  • Exhibit 98: Epic Pharma LLC - Key offerings
  • 10.5 F. Hoffmann La Roche Ltd.
  • Exhibit 99: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 100: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 101: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 102: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 103: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.6 Johnson and Johnson
  • Exhibit 104: Johnson and Johnson - Overview
  • Exhibit 105: Johnson and Johnson - Business segments
  • Exhibit 106: Johnson and Johnson - Key news
  • Exhibit 107: Johnson and Johnson - Key offerings
  • Exhibit 108: Johnson and Johnson - Segment focus
  • 10.7 Lannett Co. Inc.
  • Exhibit 109: Lannett Co. Inc. - Overview
  • Exhibit 110: Lannett Co. Inc. - Business segments
  • Exhibit 111: Lannett Co. Inc. - Key news
  • Exhibit 112: Lannett Co. Inc. - Key offerings
  • Exhibit 113: Lannett Co. Inc. - Segment focus
  • 10.8 Novo Nordisk AS
  • Exhibit 114: Novo Nordisk AS - Overview
  • Exhibit 115: Novo Nordisk AS - Business segments
  • Exhibit 116: Novo Nordisk AS - Key offerings
  • Exhibit 117: Novo Nordisk AS - Segment focus
  • 10.9 Pfizer Inc.
  • Exhibit 118: Pfizer Inc. - Overview
  • Exhibit 119: Pfizer Inc. - Product / Service
  • Exhibit 120: Pfizer Inc. - Key news
  • Exhibit 121: Pfizer Inc. - Key offerings
  • 10.10 Recordati SpA
  • Exhibit 122: Recordati SpA - Overview
  • Exhibit 123: Recordati SpA - Business segments
  • Exhibit 124: Recordati SpA - Key offerings
  • Exhibit 125: Recordati SpA - Segment focus
  • 10.11 Teva Pharmaceutical Industries Ltd.
  • Exhibit 126: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 127: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 128: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 130: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 10.12 VIVUS LLC
  • Exhibit 131: VIVUS LLC - Overview
  • Exhibit 132: VIVUS LLC - Business segments
  • Exhibit 133: VIVUS LLC - Key news
  • Exhibit 134: VIVUS LLC - Key offerings
  • Exhibit 135: VIVUS LLC - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 136: Inclusions checklist
  • Exhibit 137: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 138: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 139: Research methodology
  • Exhibit 140: Validation techniques employed for market sizing
  • Exhibit 141: Information sources
  • 11.5 List of abbreviations
  • Exhibit 142: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Distribution Channel - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Distribution Channel - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Distribution Channel
  • Exhibits27: Data Table on Comparison by Distribution Channel
  • Exhibits28: Chart on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Hospital pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Hospital pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Retail pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Retail pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Retail pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Online pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Online pharmacy - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Online pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Online pharmacy - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Distribution Channel ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Market opportunity By Geographical Landscape ($ million)
  • Exhibits87: Impact of drivers and challenges in 2021 and 2026
  • Exhibits88: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits89: Overview on factors of disruption
  • Exhibits90: Impact of key risks on business
  • Exhibits91: Vendors covered
  • Exhibits92: Matrix on vendor position and classification
  • Exhibits93: Arena Pharmaceuticals Inc. - Overview
  • Exhibits94: Arena Pharmaceuticals Inc. - Product / Service
  • Exhibits95: Arena Pharmaceuticals Inc. - Key offerings
  • Exhibits96: Epic Pharma LLC - Overview
  • Exhibits97: Epic Pharma LLC - Product / Service
  • Exhibits98: Epic Pharma LLC - Key offerings
  • Exhibits99: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits100: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits101: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits102: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits103: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits104: Johnson and Johnson - Overview
  • Exhibits105: Johnson and Johnson - Business segments
  • Exhibits106: Johnson and Johnson - Key news
  • Exhibits107: Johnson and Johnson - Key offerings
  • Exhibits108: Johnson and Johnson - Segment focus
  • Exhibits109: Lannett Co. Inc. - Overview
  • Exhibits110: Lannett Co. Inc. - Business segments
  • Exhibits111: Lannett Co. Inc. - Key news
  • Exhibits112: Lannett Co. Inc. - Key offerings
  • Exhibits113: Lannett Co. Inc. - Segment focus
  • Exhibits114: Novo Nordisk AS - Overview
  • Exhibits115: Novo Nordisk AS - Business segments
  • Exhibits116: Novo Nordisk AS - Key offerings
  • Exhibits117: Novo Nordisk AS - Segment focus
  • Exhibits118: Pfizer Inc. - Overview
  • Exhibits119: Pfizer Inc. - Product / Service
  • Exhibits120: Pfizer Inc. - Key news
  • Exhibits121: Pfizer Inc. - Key offerings
  • Exhibits122: Recordati SpA - Overview
  • Exhibits123: Recordati SpA - Business segments
  • Exhibits124: Recordati SpA - Key offerings
  • Exhibits125: Recordati SpA - Segment focus
  • Exhibits126: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits127: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits128: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits129: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits130: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits131: VIVUS LLC - Overview
  • Exhibits132: VIVUS LLC - Business segments
  • Exhibits133: VIVUS LLC - Key news
  • Exhibits134: VIVUS LLC - Key offerings
  • Exhibits135: VIVUS LLC - Segment focus
  • Exhibits136: Inclusions checklist
  • Exhibits137: Exclusions checklist
  • Exhibits138: Currency conversion rates for US$
  • Exhibits139: Research methodology
  • Exhibits140: Validation techniques employed for market sizing
  • Exhibits141: Information sources
  • Exhibits142: List of abbreviations